Healios KK
F:6VX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Healios KK
F:6VX
|
JP |
|
C
|
China Overseas Land & Investment Ltd
SWB:CPP
|
HK |
|
C
|
China Overseas Land & Investment Ltd
XMUN:CPP
|
HK |
|
C
|
China Overseas Land & Investment Ltd
F:CPP
|
HK |
|
Fanuc Corp
F:FUCA
|
JP |
|
S
|
Sega Sammy Holdings Inc
XMUN:RYU
|
JP |
|
Arkema SA
PAR:AKE
|
FR |
Intrinsic Value
Is 6VX undervalued or overvalued?
See the intrinsic value estimate for 
Healios KK and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Healios KK Does
Healios KK is a Japanese biotechnology company that develops regenerative medicine and cell therapy products. Its core work is to turn living cells into treatments for serious conditions such as stroke and acute respiratory failure, then move those therapies through testing, approval work, and partnering. It is not a traditional drugmaker with a wide catalog of medicines; it is closer to a specialist developer of advanced therapies.
- Headquarters
- Japan JP
- Employees
- 75
- IPO date
- Jun 16, 2015
Revenue & Expenses Breakdown
Healios KK
Earnings Waterfall
Healios KK
The intrinsic value for Healios KK (6VX) under the Base Case is hidden EUR.
Compared with the current market price of 1.49 EUR, the stock appears hidden.